Shanghai Yizhong Pharmaceutical Past Performance
Past criteria checks 3/6
Shanghai Yizhong Pharmaceutical has been growing earnings at an average annual rate of 90.8%, while the Pharmaceuticals industry saw earnings growing at 8.8% annually. Revenues have been growing at an average rate of 665.3% per year. Shanghai Yizhong Pharmaceutical's return on equity is 12.1%, and it has net margins of 56.8%.
Key information
90.8%
Earnings growth rate
92.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 8.8% |
| Revenue growth rate | 665.3% |
| Return on equity | 12.1% |
| Net Margin | 56.8% |
| Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
No updates
Recent updates
Earnings and Revenue History
Quality Earnings: 688091 has a high level of non-cash earnings.
Growing Profit Margin: 688091's current net profit margins (56.8%) are lower than last year (83.9%).
Past Earnings Growth Analysis
Earnings Trend: 688091 has become profitable over the past 5 years, growing earnings by 90.8% per year.
Accelerating Growth: 688091's earnings growth over the past year (418.2%) exceeds its 5-year average (90.8% per year).
Earnings vs Industry: 688091 earnings growth over the past year (418.2%) exceeded the Pharmaceuticals industry 15.3%.
Return on Equity
High ROE: 688091's Return on Equity (12.1%) is considered low.